About Us
News & Events
Partnerships
Careers
Publications
About microRNAs
Therapeutic Opportunities
Drugs & Technologies
Learn More About Us
Publications
11.30.08
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
read more
11.16.08
Potent inhibition of microRNA in vivo without degradation
read more
News
01.25.10
Regulus, Alnylam and Isis Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21
read more
01.15.10
Regulus Therapeutics Present New Pre-clinical Data from Multiple Therapeutic Programs at Keystone Symposium
read more
